title: Bendamustine-induced "flagellate dermatitis".
abstract: BACKGROUND
  The term "flagellate erythema" after bleomycin therapy was described as bleomycin-induced linear hyperpigmentation. Since then, this pattern has not been related to any other chemotherapeutic regimen.
  
  
  METHODS
  We report a rare patient with chronic lymphocytic leukemia who developed "flagellate dermatitis" induced by bendamustine.
  
  
  CONCLUSIONS
  Chemotherapy induced "Flagellate Dermatitis" is a rare finding reported only after bleomycin therapy. We describe the first case with this characteristic eruption pattern after administration of bendamustine.
authors.affiliation: Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA.
authors.forename: Bassel H
authors.initials: BH
authors.lastname: Mahmoud
authors.forename: Melody J
authors.initials: MJ
authors.lastname: Eide
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects* / Q000627:therapeutic use; D000069461:Bendamustine Hydrochloride; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018906:Antineoplastic Agents, Alkylating; D009588:Nitrogen Mustard Compounds; D000069461:Bendamustine Hydrochloride